Zhongquan Sun

2.1k total citations · 1 hit paper
64 papers, 1.3k citations indexed

About

Zhongquan Sun is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zhongquan Sun has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Zhongquan Sun's work include Prostate Cancer Treatment and Research (10 papers), Bladder and Urothelial Cancer Treatments (8 papers) and RNA modifications and cancer (7 papers). Zhongquan Sun is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Bladder and Urothelial Cancer Treatments (8 papers) and RNA modifications and cancer (7 papers). Zhongquan Sun collaborates with scholars based in China, United States and United Kingdom. Zhongquan Sun's co-authors include Weilin Wang, Yuan Ding, Zhengwei Mao, Zongrui Tong, Sitong Zhang, Liuzhi Zhou, Qianhui Xu, Sheng Yan, Binglin Ye and Zhefeng Qian and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhongquan Sun

63 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial‐Targeted Delivery of Polyphenol‐Mediated Antioxidases Complexes against Pyroptosis and Inflammatory Diseases

2023 156 citations Zhongquan Sun, Yuan Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhongquan Sun China	17	460	360	295	213	203	64	1.3k
Reza Akhavan‐Sigari Germany	17	353 0.8×	475 1.3×	254 0.9×	204 1.0×	244 1.2×	86	1.6k
Guodong Cao China	19	513 1.1×	430 1.2×	446 1.5×	182 0.9×	208 1.0×	48	1.3k
Naishun Liao China	25	656 1.4×	473 1.3×	310 1.1×	197 0.9×	214 1.1×	53	1.4k
Jianping Dou China	20	448 1.0×	319 0.9×	201 0.7×	141 0.7×	207 1.0×	61	1.2k
Yi Dai China	18	505 1.1×	475 1.3×	573 1.9×	191 0.9×	96 0.5×	72	1.6k
Jiani Yang China	20	575 1.3×	481 1.3×	273 0.9×	246 1.2×	133 0.7×	66	1.4k
Xiaowei Ma China	20	704 1.5×	464 1.3×	331 1.1×	198 0.9×	205 1.0×	49	1.6k
Guiyang Hao United States	22	311 0.7×	504 1.4×	338 1.1×	288 1.4×	195 1.0×	52	1.7k
Quancheng Kan China	16	352 0.8×	486 1.4×	206 0.7×	163 0.8×	225 1.1×	30	1.2k

Countries citing papers authored by Zhongquan Sun

Since Specialization

Citations

This map shows the geographic impact of Zhongquan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongquan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongquan Sun more than expected).

Fields of papers citing papers by Zhongquan Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongquan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongquan Sun. The network helps show where Zhongquan Sun may publish in the future.

Co-authorship network of co-authors of Zhongquan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongquan Sun. A scholar is included among the top collaborators of Zhongquan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongquan Sun. Zhongquan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Yang, Xiang Zhang, Zhongquan Sun, et al.. (2024). Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network. Advanced Science. 12(4). e2404671–e2404671. 6 indexed citations

Li, Siming, Yanxia Shi, Haiying Dong, et al.. (2024). Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China. Cancer Medicine. 13(21). e70368–e70368. 4 indexed citations

Sun, Qiang, Xuesong Bai, Zhongquan Sun, et al.. (2024). Adult split liver transplantation to treat liver cancer: a single-center retrospective study. World Journal of Emergency Medicine. 16(1). 57–57.

Sun, Zhongquan, et al.. (2024). V9302-loaded copper-polyphenol hydrogel for enhancing the anti-tumor effect of disulfiram. Journal of Colloid and Interface Science. 678(Pt B). 866–877. 8 indexed citations

Wang, Haishuai, et al.. (2024). Anchored-fusion enables targeted fusion search in bulk and single-cell RNA sequencing data. Cell Reports Methods. 4(3). 100733–100733. 2 indexed citations

Zhang, Lufei, et al.. (2023). 5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I. Frontiers of Medicine. 17(3). 476–492. 17 indexed citations

Qin, Xiaojian, Dongmei Ji, Weijie Gu, et al.. (2022). Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial. BMC Medicine. 20(1). 84–84. 10 indexed citations

Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2021). Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma. BioMed Research International. 2021(1). 7020637–7020637. 15 indexed citations

Qu, Yuanyuan, Qing Zou, Hongqian Guo, et al.. (2021). Camrelizumab plus famitinib for advanced renal cell carcinoma or unresectable urothelial carcinoma: Updated results from a phase II trial.. Journal of Clinical Oncology. 39(15_suppl). 4550–4550. 2 indexed citations

10.

Ding, Yuan, Zhongquan Sun, Zongrui Tong, et al.. (2020). Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy. Theranostics. 10(12). 5195–5208. 93 indexed citations

11.

Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2020). Identification of snoRNA SNORA71A as a Novel Biomarker in Prognosis of Hepatocellular Carcinoma. Disease Markers. 2020. 1–7. 15 indexed citations

12.

Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2020). Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and its Clinical Significance. Journal of Cancer. 11(11). 3369–3374. 14 indexed citations

13.

Ding, Yuan, Zhenzhen Gao, Zhongquan Sun, et al.. (2018). Enhanced recovery program in liver resection surgery: a single center experience. Translational Cancer Research. 7(4). 1112–1121. 1 indexed citations

14.

Yuan, Ding, Zhenzhen Gao, Zhongquan Sun, et al.. (2018). Enhanced recovery program in liver resection surgery: a single center experience. Translational Cancer Research. 7(4). 1112–1121. 4 indexed citations

15.

Lü, Sheng, et al.. (2016). Treatment of Ureteral Fibroepithelial Polyp by Ureteroscopy Combined with Holmium Laser or Thulium Laser: A Retrospective Study. Photomedicine and Laser Surgery. 34(10). 456–459. 13 indexed citations

16.

Sun, Yinghao, Qing Zou, Zhongquan Sun, et al.. (2016). Abiraterone acetate for metastatic castration‐resistant prostate cancer after docetaxel failure: A randomized, double‐blind, placebo‐controlled phase 3 bridging study. International Journal of Urology. 23(5). 404–411. 28 indexed citations

17.

Zhang, Haojie, et al.. (2015). New Therapeutic Schedule for Prostatic Cancer-3 Cells with ET-1 RNAi and Endostar. Asian Pacific Journal of Cancer Prevention. 15(23). 10079–10083. 2 indexed citations

18.

Sun, Zhongquan, Zhiyong Yu, Songfeng Yu, et al.. (2015). Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China. PLoS ONE. 10(8). e0135557–e0135557. 11 indexed citations

19.

Peyromaure, Michaël, B Debré, Kaili Mao, et al.. (2005). MANAGEMENT OF PROSTATE CANCER IN CHINA: A MULTICENTER REPORT OF 6 INSTITUTIONS. The Journal of Urology. 174(5). 1794–1797. 44 indexed citations

20.

Sun, Zhongquan, et al.. (2005). [The study of diagnosis and treatment of interstitial cystitis].. PubMed. 43(10). 659–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact